Form 4: ARS Pharmaceuticals' Chief Medical Officer Sarina Tanimoto Sells Shares
SEC Form 4 Filing
Sarina Tanimoto, Chief Medical Officer of ARS Pharmaceuticals, executed sales of common stock on December 17, 2024, according to a recent SEC filing.
Summary
- Sarina Tanimoto, the Chief Medical Officer of ARS Pharmaceuticals, sold 50,000 shares of common stock on December 17, 2024.
- The sales were executed at weighted average prices of $11.6715 and $11.6705 per share.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan established on March 31, 2023.
- Following the reported transactions, Tanimoto directly owns 3,433,512 shares of common stock.
- Tanimoto also has indirect ownership through various trusts, including the Sarina Tanimoto Charitable Remainder UniTrust, the Lowenthal-Tanimoto Family Trust, and trusts held by her spouse.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock sales by an insider. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.
Industry Context
This filing is a routine disclosure of insider trading activity. It's common for executives to have pre-arranged trading plans to sell shares over time.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 01/07/2020 | Date of Sarina Tanimoto Charitable Remainder UniTrust and Richard E. Lowenthal Charitable Remainder UniTrust |
| 04/03/2006 | Date of Lowenthal-Tanimoto Family Trust U/A |
| 03/31/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 12/17/2024 | Date of stock sale transactions |
| 12/19/2024 | Date of signature on the SEC filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.